Carregant...
Finding new lanes: Chimeric antigen receptor (CAR) T‐cells for myeloid leukemia
BACKGROUND: Myeloid leukemia represents a heterogeneous group of cancers of blood and bone marrow which arise from clonal expansion of hematopoietic myeloid lineage cells. Acute myeloid leukemia (AML) has traditionally been treated with multi‐agent chemotherapy, but conventional therapies have not i...
Guardat en:
| Publicat a: | Cancer Rep (Hoboken) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941581/ https://ncbi.nlm.nih.gov/pubmed/32671999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1222 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|